Dr. Robert Jason Sporter, MD

Dr. Sporter practices at ENT and Allergy Associates in New York, New York.

Dr. Sporter's NPI, 1568697191, was assigned on May 27, 2009. Dr. Sporter graduated from New York Medical College in 2008. Dr. Sporter holds New York license 254401.

Dr. Sporter's primary practice is ENT and Allergy Associates, at 261 5th Ave, New York, NY 10016 in New York County. The practice phone is (914) 333-5800.

Dr. Sporter's primary practice is ENT and Allergy Associates in New York, New York. The medical group on file is ENT and Allergy Associates. Dmand AI also links Dr. Sporter to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sporter practices. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Sporter's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Sporter is licensed in New York.

CMS data shows 2,788 Medicare services from Dr. Sporter across 5 procedure codes in 2024, for 93 Medicare patients. Medicare paid $20,928 for them. Every service was in an office.

CMS counts 93 Medicare patients who saw Dr. Sporter in 2024. The largest group is 65 to 74, with 51 patients. 74% of them have high cholesterol, and 55% have high blood pressure. 12% are also on Medicaid. Their average risk score is 0.81, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sporter's median patient age at 33, with 51% women.

In 2024, Dr. Sporter wrote 276 Medicare Part D claims for 62 patients. 66% of them were for generic drugs. CMS names the drug for 201 of them, across 10 drugs with 11 or more claims each, at $64,914 in total drug cost. In 2023, CMS named 190 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Sporter for performance year 2024, reported as part of a group. Dr. Sporter accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Sporter, published from 2016 to 2021. Dr. Sporter's most frequent co-authors are Sheila Margarita Bina, MD, Vincent R. Bonagura, MD and Catherine Capo, MD.

CMS Open Payments shows 1,806 general payments to Dr. Sporter from 46 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 77% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $474,780.

Dr. Sporter graduated from New York Medical College in 2008.